Literature DB >> 10485508

The economic burden associated with colon cancer in the United States.

R Seifeldin1, J J Hantsch.   

Abstract

Colon cancer, the second most frequent cause of cancer deaths in the United States, is primarily a disease of the elderly. As the current population ages in the coming decades, the economic burden of colon cancer is expected to increase substantially. The primary objective of this study was to estimate the economic burden of hospitalizations for colon cancer. Secondary objectives were to assess the relationship between risk factors, including age, and treatment charges and to estimate the number of hospital admissions through the year 2050. We examined hospital discharge data for the years 1991 through 1994 from the Healthcare Cost and Utilization Project of the US Agency for Health Care Policy and Research to assess the characteristics of hospitalizations forcolon cancer in the United States. Census data were used to project the annual number of admissions through the year 2050. The mean number of admissions for colon cancer was 237,754 per year, the mean length of stay was 11.1 days per admission, and mean total hospital charges were $4.57 billion per year. Most of the charges were incurred by people aged > or = 60 years (83.08%) and by people with no known risk factors for colon cancer (93.96%). Based on census projections, between 1992 and 2050 the annual number of colon cancer-related admissions will increase from 215,000 to 471,000 in people aged > or = 50 years and from 192,000 to 448,000 in people aged > or = 60 years. Knowledge of additional risk factors and more effective preventive, screening, diagnostic, and treatment procedures may help prevent the predicted increase in colon cancer-related hospitalizations in the next century.

Entities:  

Mesh:

Year:  1999        PMID: 10485508     DOI: 10.1016/s0149-2918(99)80037-x

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  9 in total

1.  Exploratory metabolomic study to identify blood-based biomarkers as a potential screen for colorectal cancer.

Authors:  Isaac Asante; Hua Pei; Eugene Zhou; Siyu Liu; Darryl Chui; EunJeong Yoo; David V Conti; Stan G Louie
Journal:  Mol Omics       Date:  2019-02-11

2.  Dietary fiber enhances a tumor suppressor signaling pathway in the gut.

Authors:  Khoa A Nguyen; Yanna Cao; Justin R Chen; Courtney M Townsend; Tien C Ko
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

3.  Economic burden of cancer survivorship among adults in the United States.

Authors:  Gery P Guy; Donatus U Ekwueme; K Robin Yabroff; Emily C Dowling; Chunyu Li; Juan L Rodriguez; Janet S de Moor; Katherine S Virgo
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

4.  The Medical Expenditure Panel Survey (MEPS) experiences with cancer survivorship supplement.

Authors:  K Robin Yabroff; Emily Dowling; Juan Rodriguez; Donatus U Ekwueme; Helen Meissner; Anita Soni; Catherine Lerro; Gordon Willis; Laura P Forsythe; Laurel Borowski; Katherine S Virgo
Journal:  J Cancer Surviv       Date:  2012-07-19       Impact factor: 4.442

5.  Colorectal cancer in geriatric patients: endoscopic diagnosis and surgical treatment.

Authors:  Andreas Kirchgatterer; Pius Steiner; Dietmar Hubner; Eva Fritz; Gerhard Aschl; Josef Preisinger; Maximilian Hinterreiter; Bernhard Stadler; Peter Knoflach
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

Review 6.  Cost considerations in the treatment of colorectal cancer.

Authors:  Frank G A Jansman; Maarten J Postma; Jacobus R B J Brouwers
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 7.  Screening, prevention and socioeconomic costs associated with the treatment of colorectal cancer.

Authors:  Alberto Redaelli; Carole W Cranor; Gary J Okano; Pat Ray Reese
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

8.  Cost effectiveness of interventions to promote screening for colorectal cancer: a randomized trial.

Authors:  Swati Misra; David R Lairson; Wenyaw Chan; Yu Chia Chang; L Kay Bartholomew; Anthony Greisinger; Amy McQueen; Sally W Vernon
Journal:  J Prev Med Public Health       Date:  2011-05

9.  Optimising surgical management of elderly cancer patients.

Authors:  Hodigere Sripathy Jois Ramesh; Daniel Pope; Roberto Gennari; Riccardo A Audisio
Journal:  World J Surg Oncol       Date:  2005-03-23       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.